GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oscar Health OSCR · USD

Financials · US listing · 🇺🇸 United States

Compare

32.14

+4.86%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

−$443.2m

FY2019FY2025

Total assets

$6.33bn

FY2019FY2025

Shareholders' equity

$977.6m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating income−$419.7m$57.3m−$242.8m−$587.5m−$565.9m−$402.3m−$259.4m
Net income−$443.2m$25.4m−$270.7m−$606.3m−$572.6m−$406.8m−$261.2m
Diluted earnings per share-1.560.10-1.19-2.82-2.73-13.46-9.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets$6.33bn$4.84bn$3.60bn$4.53bn$3.32bn$2.27bn$1.35bn
Cash and short-term investments$3.99bn$2.15bn$2.56bn$2.96bn$1.69bn$1.19bn$670.4m
Total liabilities$5.34bn$3.82bn$2.80bn$3.63bn$1.93bn$3.57bn$494.2m
Debt$430.1m$299.6m$298.8m$298.0m—$142.5m—
Shareholders' equity$977.6m$1.01bn$804.0m$890.4m$1.39bn−$1.30bn$852.7m
Shares outstanding283m266m227m215m210m30m29m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income$387.7m$704.1m−$333.7m−$132.4m−$227.7m$297.1m−$147.7m−$46.5m
Net income$361.8m$679.0m−$352.6m−$137.4m−$228.4m$275.3m−$153.5m−$54.6m
Diluted earnings per share1.092.04-1.24-0.49-0.810.97-0.58-0.21
Total assets$11.23bn$9.29bn$6.33bn$5.75bn$6.38bn$5.84bn$4.84bn$4.48bn
Cash and short-term investments$8.56bn$6.80bn$3.99bn$3.04bn$3.54bn$2.99bn$2.15bn$1.71bn
Debt$431.6m$430.9m$430.1m$686.3m$299.9m$299.7m$299.6m$299.4m
Shareholders' equity$2.05bn$1.66bn$977.6m$1.02bn$1.16bn$1.33bn$1.01bn$1.16bn

Financial ratios

Data as of 22 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-3.6%0.6%-4.0%-14.2%-29.5%-68.2%
Net margin-3.8%0.3%-4.6%-14.7%-29.8%-69.0%
Return on equity-45.3%2.5%-33.7%-68.1%-41.3%31.4%
Return on assets-7.0%0.5%-7.5%-13.4%-17.2%-17.9%
Revenue growth27.5%56.5%42.1%114.8%225.8%6.5%
Earnings growth-1842.5%-109.4%-55.3%5.9%40.7%55.8%
Current ratio0.95x0.90x-11.82x1.40x1.71x2.68x
Debt to equity0.44x0.30x0.37x0.33x—-0.11x
Equity ratio15.5%20.9%22.3%19.7%41.8%-57.0%
Interest coverage-23.86x2.41x-9.58x-25.97x-119.89x-114.48x
Buybacks as a share of market value-6.5%-17.1%-5.5%-2.6%-593.9%-4.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue42.1%82.4%—
Operating income-10.6%0.9%—
Net income-9.9%1.7%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-1.7%-3.9%-6.5%—
Net margin-2.0%-4.2%-6.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-9.2140.5-7.7-0.9-2.9
Price to sales0.30.40.40.10.9

Market value over time

31 Mar 2021 to 14 Oct 2026, in USD

$2.39bn$11.44bn

Share price return

Finished calendar years

20252024202320222021
Return11%67%262%-72%-78%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.